A Study of PHN-012 in Patients With Advanced Solid Tumors
Pheon Therapeutics
Pheon Therapeutics
Kivu Bioscience Inc.
Kestrel Therapeutics, Inc.
AbbVie
Nammi Therapeutics Inc
National Cancer Institute (NCI)
Bristol-Myers Squibb
National Institutes of Health Clinical Center (CC)
Jazz Pharmaceuticals
Pfizer
Alterome Therapeutics, Inc.
Verastem, Inc.
EMD Serono
AstraZeneca
Memorial Sloan Kettering Cancer Center
Eli Lilly and Company
Institut Paoli-Calmettes
RasCal Therapeutics, Inc.
Frontier Medicines Corporation
Filamon LTD
Origin Sciences
UMC Utrecht
ViroMissile, Inc.
Massachusetts General Hospital
Sichuan Enray Pharmaceutical Sciences Company
A2 Biotherapeutics Inc.
Arvinas Inc.
Tasca Therapeutics
Essen Biotech
National Institutes of Health Clinical Center (CC)
MBrace Therapeutics
Azienda Ospedaliero-Universitaria di Parma
A2 Biotherapeutics Inc.
Revolution Medicines, Inc.
MacroGenics
Poitiers University Hospital
Revolution Medicines, Inc.
Auricula Biosciences Inc.
Daiichi Sankyo
University of Nebraska
Zhejiang University
EXoPERT
Adela, Inc
Natera, Inc.
Eli Lilly and Company
University of Rochester
Var2 Pharmaceuticals
PAQ Therapeutics, Inc.
Mayo Clinic
Tyligand Pharmaceuticals (Suzhou) Limited